Scott Rocklage Helps Healthcare Through Growing Businesses

The combination of business and healthcare is an inexhaustible commodity in the market. Scientist and businessman Dr. Scott Rocklage is a prime example of the success that can be found in helping to grow business ventures that ultimately improve the health of others. Learn more:


Rocklage joined his current firm, 5AM Ventures, in 2003. He started as a Venture Partner, and due to his exceptional knowledge and leadership skills he was quickly promoted to a Managing Partner in 2004. 5AM Ventures is a healthcare investment firm that seeks to help other companies expand or conduct clinical trials for medication. In fact, Rocklage has overseen the creation of three new prescription medications that were released to market with FDA approval.


Much of Rocklage’s success can be attributed to how he balances the aspects of the uncommon workday for a healthcare entrepreneur. He stays heavily involved in managing portfolio companies, which includes attending board meetings and helping to enhance business models for other managers. However, Scott Rocklage is a scientist at heart and dedicates a considerable amount of time to researching new advancements in the life science field of study.


Due to his education and experience, Scott Rocklage possesses a wealth of information regarding chemistry and the field of life science. He has put much of this knowledge into writing and currently has over 100 peer-reviewed publications to his name. As an inventor, Rocklage has been involved in over 30 patents that are registered in the United States. Currently, Scott Rocklage has more than 30 years of experience in managing healthcare businesses and is based out of the Boston area.


Dr. Scott Rocklage is a graduate of the University of California at Berkeley where he was the recipient of a Bachelor’s degree in Chemistry. Rocklage went on to earn his Ph.D. in Chemistry from the Massachusetts Institute of Technology, where he was involved in research in the laboratory of Nobel Prize winner Richard R. Schrock. Prior to 5AM Ventures, Scott Rocklage served as a chairman for Novira and Relypsa. He was also on the board for Cubist Pharmaceuticals, in addition to serving as the company’s CEO.